Palantir (PLTR) shares are trading between the $20 to $25 range. Amgen (AMGN) is coming out of the GLP-1 Phase 3 trial with a once a month delivery versus once a week. Is the stock relatively cheap currently? Finally, Kenny Polcari weighs in on Lockheed Martin (LMT), which has been flat on the year and underperforming its competitors. Ben Lichtenstein provides a technical analysis take on PLTR, AMGN, and LMT.
Trading 360
17 Jun 2024
SHARE